Notice2023-01695

Proposed Update to the CDC Framework for Program Evaluation in Public Health; Extension of Comment Period

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
January 27, 2023

Issuing agencies

Health and Human Services DepartmentCenters for Disease Control and Prevention

Abstract

The Centers for Disease Control and Prevention (CDC), within the Department of Health and Human Services (HHS), announces the extension of the comment period for the update to the CDC Framework for Program Evaluation in Public Health (CDC Evaluation Framework) and associated resources (e.g., checklists, self-study guide).

Full Text

<html>
<head>
<title>Federal Register, Volume 88 Issue 18 (Friday, January 27, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 18 (Friday, January 27, 2023)]
[Notices]
[Pages 5347-5348]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-01695]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2022-0137]


Proposed Update to the CDC Framework for Program Evaluation in 
Public Health; Extension of Comment Period

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Request for information and extension of comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), within 
the Department of Health and Human Services (HHS), announces the 
extension of the comment period for the update to the CDC Framework for 
Program Evaluation in Public Health (CDC Evaluation Framework) and 
associated resources (e.g., checklists, self-study guide).

DATES: Written comments must be received on or before February 17, 
2023. Comments received after February 17, 2023, will not be 
considered.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0137 by either of the methods listed below. Do not submit comments by 
email. CDC does not accept comments by email.
    <bullet> Federal eRulemaking Portal: <a href="http://www.regulations.gov">http://www.regulations.gov</a>. 
Follow the instructions for submitting comments.
    <bullet> Mail: Centers for Disease Control and Prevention, Program 
Performance and Evaluation Office, 1600 Clifton Road NE, Mailstop H21-
10, Atlanta, GA 30329-4027.
    Instructions: All submissions received must include the agency name 
and Docket Number. All relevant comments received will be posted 
without change to <a href="http://regulations.gov">http://regulations.gov</a>, including any personal 
information provided. For access to the docket to read background 
documents or comments received, go to <a href="http://www.regulations.gov">http://www.regulations.gov</a>.

FOR FURTHER INFORMATION CONTACT: Daniel Kidder, CDC Chief Evaluation 
Officer, Centers for Disease Control and Prevention, Program 
Performance and Evaluation Office, 1600 Clifton Road NE, Mailstop H21-
10, Atlanta, GA

[[Page 5348]]

30329-4027; Telephone: 404-639-6270; Email: <a href="/cdn-cgi/l/email-protection#febdbabd9b889f92be9d9a9dd0999188"><span class="__cf_email__" data-cfemail="723136311704131e321116115c151d04">[email&#160;protected]</span></a>.

SUPPLEMENTARY INFORMATION: On November 29, 2022, CDC published a notice 
requesting public comment and suggestions to update the CDC Evaluation 
Framework (87 FR 73311). The comment period was scheduled to close on 
January 30, 2023. CDC has received requests from the public to extend 
the comment period. With this notice, CDC is extending the comment 
period through February 17, 2023, to accommodate those requests. 
Comments received after February 17, 2023, will not be considered.

Background

    The flexibility and simplicity of the CDC Evaluation Framework have 
led to its wide adoption and use beyond CDC and public health. The CDC 
Evaluation Framework has guided CDC and other evaluators over two 
decades, as evidenced by more than 300 citations in peer-reviewed 
articles and use in projects reaching more than 50 countries on six 
continents. However, evaluation has evolved since publication of the 
framework in 1999; \1\ therefore, CDC seeks to update the framework to 
align with changes in evaluation, public health, and federal policies 
and practices.
---------------------------------------------------------------------------

    \1\ Centers for Disease Control and Prevention. Framework for 
program evaluation in public health. MMWR 1999;48 (No. RR-11).
---------------------------------------------------------------------------

    The comments from this request for information, along with input 
gathered through other mechanisms (e.g., townhall with CDC, interviews 
with key federal evaluators, surveys with federal evaluation staff and 
leaders), will help identify how the framework may have been adapted 
and used in different settings, what aspects of the framework have been 
useful, any challenges in using the framework across different 
contexts, and gaps that may need to be addressed. CDC is gathering 
input from a variety of audiences, such as federal evaluators, CDC 
staff, and CDC funded partners. Feedback from these sources will be 
considered in determining priority areas to update and revise in the 
CDC Evaluation Framework to continue its valuable use and service to 
the evaluation field and public health. The relevant feedback along 
with tools, evidence, and resources in the field and literature will 
also be considered in determining whether to update, revise, or create 
new content for the CDC Evaluation Framework and supporting resources 
(e.g., checklists, tools).

Request for Information

    Interested persons or organizations are invited to submit written 
views, information, and recommendations. CDC invites comments 
specifically on the following questions, along with suggestions for 
improving the CDC Evaluation Framework:
    1. How has the current CDC Evaluation Framework assisted or not 
assisted the public health community in planning and conducting high-
quality program evaluations? What specifically helped or did not help?
    2. Which contexts has the current CDC Evaluation Framework worked 
well for and for which contexts has it not worked well? What 
specifically did or did not work and why?
    3. How does the current CDC Evaluation Framework promote or inhibit 
the conduct of evaluations that are culturally responsive and address 
health equity? What opportunities for improvement exist?
    Please be clear and specific in the comments so that CDC can 
consider the feedback provided in determining whether to change or keep 
specific aspects of the CDC Evaluation Framework. The CDC Evaluation 
Framework and associated resources can be found here in the Supporting 
Materials tab of the docket and at <a href="https://www.cdc.gov/evaluation/framework/index.htm">https://www.cdc.gov/evaluation/framework/index.htm</a>.
    Please note that comments received, including attachments and other 
supporting materials, are part of the public record and are subject to 
public disclosure. Comments will be posted on <a href="https://www.regulations.gov">https://www.regulations.gov</a>. Therefore, do not include any information in your 
comment or supporting materials that you consider confidential or 
inappropriate for public disclosure. If you include your name, contact 
information, or other information that identifies you in the body of 
your comments, that information will be on public display. CDC will 
review all submissions and may choose to redact, or withhold 
submissions containing private or proprietary information such as 
Social Security numbers, medical information, inappropriate language, 
or duplicate/near duplicate examples of a mass-mail campaign.

Tiffany Brown,
Acting Executive Secretary, Centers for Disease Control and Prevention.
[FR Doc. 2023-01695 Filed 1-26-23; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on January 27, 2023.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.